Upon this ROC I will build…

I was considering writing an April Fools day post, but life’s too short to not blog about epidemiology and epistemology.

As is often the case when I go back to Yale for alumni debates, I ended up in some extended theological debates.  In a conversation with one friend, we ended up on thse topic that used to form the core of my about section: what evidence would persuade me that Christianity (or another religion) is true?

I think it’s possible that I’ve set the bar for proof so high that even a true religion couldn’t pass (it’s probably not a good sign when your possible proofs are physically impossible under current models of physics).  On the other hand, I certainly don’t want to keep my mind so open that my brain falls out.  But talking only in terms of these two extremes isn’t very helpful, so let’s all take a brief biostatistics detour, and see if it helps.  (It was extremely useful in my discussion this weekend).

When you’re evaluating a diagnostic test in epidemiology, there are two statistics you really care about:

  • Sensitivity – How often does our test successfully return positive results for true cases of the disease?  Sensitivity is calculated as (# of sick people correctly identified as sick)/(# of sick people total)
  • Specificity – How precise is our test?  Can we be confident a positive result really means the person is sick?  Specificity is calculated as (# of healthy people with a negative test result)/(# of healthy people total)

You can think of sensitivity as the true positive rate and specificity as the true negative rate.  In a perfect world, both statistics would be 100%, but that almost never happens.  We have to decide whether we care more about definitely finding every one who’s sick or if there’s a risk in casting our net too widely.  The TSA prefers high sensitivity screening, even if it’s a big inconvenience for non-terrorists.  When it comes to prostate cancer, we need better specificity, because treatment does more harm than good for a lot of people who test positive.

So what we do is move around our positive test cutoff to what seems like the optimal point.  To try and find that point, we draw a ROC curve.  (ROC stands for Reciever Operating Characteristic, but trust me, it’s not necessary to know what that means).  A ROC curve is a graph of the sensitivity and specificity (actually one minus the specificity) for a range of possible positive test cutoffs.  The curves look like this:

Real data is noisier than this

Usually you pick the cutoff for evidence that puts you at the ‘elbow’ — the point on the curve closest to the top left corner at (0,1), unless you’re in special circumstances like the TSA or prostate cancer oncologists.

So the question my friend and I were really kicking around is whether, when we consider religious propositions, should we stick to the standard way of thinking or is there a reason we should prioritize specificity over sensitivity or vice versa?

Generally, whenever we’re being asked to do something that clashes terribly with our moral intuitions (like, say, slaughter Isaac) it seems like it makes sense to stick with a high specificity test.  We’d rather miss a few genuine commandments and corrections in order to avoid hurting people by mistake.  But we don’t want such a low-sensitivity epistemology and standard of proof that we can never embrace a true philosophy and just stay stuck out on our own, trying to construct an entirely new edifice.

Epidemiologists have it easy.  They compute sensitivity and specificity by using a ‘gold-standard’ test (like autopsy) as a comparison to the field test.  I’m not really sure how to check the calibration of my sensitivity-specificity trade-off when it comes to ethics and philosophy.  Any suggestions?

Komen Concedes (but it still sucks)

Komen spent the last two days reaping a financial windfall from pro-life activists, after they pulled their funding for Planned Parenthood.  (Planned Parenthood had a funding surge, too, prompting a friend of mine to say the whole thing felt like a publicity stunt, or a pro-wrestling storyline).  Now, Komen has purged its new policy.

But before any pro-choice readers I’ve got decide to put the money where their mouths are, let me make a plea that you not give Komen any of your money.  Not even as a thank you for the reversal.  I agree with all the criticisms Simcha Fischer made back when Komen was on her side (they brand a lot of things, so people feel like they’ve made a difference by buying a pink Glock when only pennies of your purchase go towards research, they pressure women to be a happy face of cancer, etc).

But, since I’m a big epidemiology nerd, that’s not my real objection.  I don’t like Komen because they’ve tried to subvert the FDA’s recommendations on mammograms.  A panel of experts reviewed the data and said that, for women under 50 with no know risk factors for breast cancer, regular mammography does more harm than good.  Komen and others struck back with personal testimonies from women in this demographic who had found cancer through screening.

The stories were touching, but the plural of anecdote is not data.  It can be hard to wire the actual facts into your intuitions, so here’s a helpful story, to retrain your brain.  The numbers in this example (from David Newman, a director of clinical research at Mount Sinai School of Medicine) are about prostate cancer screening, but the gist goes for breast cancer as well:

“Imagine you are one of 100 men in a room,” he says. “Seventeen of you will be diagnosed with prostate cancer, and three are destined to die from it. But nobody knows which ones.” Now imagine there is a man wearing a white coat on the other side of the door. In his hand are 17 pills, one of which will save the life of one of the men with prostate cancer. “You’d probably want to invite him into the room to deliver the pill, wouldn’t you?” Newman says.

Statistics for the effects of P.S.A. testing are often represented this way — only in terms of possible benefit. But Newman says that to completely convey the P.S.A. screening story, you have to extend the metaphor. After handing out the pills, the man in the white coat randomly shoots one of the 17 men dead. Then he shoots 10 more in the groin, leaving them impotent or incontinent.

Newman pauses. “Now would you open that door?” He argues that the only way to measure any screening test or treatment accurately is to examine overall mortality. That means researchers must look not just at the number of deaths from the disease but also at the number of deaths caused by treatment.

If you care about women’s health, don’t give to Komen.  Give to Planned Parenthood, if you’re going for the political statement (I did).  And no matter you’re beliefs on abortion, consider giving to Against Malaria Foundation (well reviewed by GiveWell) if you want to fund a great organization truly committed to health (and data!).

Gonna Get on this Hobby Horse and Ride

I finally made time to get a flu shot at a local CVS and so now you all get treated to a public health PSA (but it’s got an ethics/duty angle, so it’s totally technically within the scope of this blog).

I could just make a pitch from self-interest: get a shot so you won’t get sick.  After all, even without insurance, the cost of the shot (~$30 at CVS) is affordable for a lot of people, and, once you’re actually sick, you’re likely to wish you could take the trade.  Plus, for people my age, the least likely to get sick, you don’t even have to pony up that much since you can be covered under your parents’ insurance til 26, now that Obamacare is in effect.  But if you think you’re fine to weather the risk, or if you’d like a slightly higher-minded reason, I’ve got a much better pitch.

When you go in for a flu shot you’ll get handed a clipboard with a checklist like this one from the CDC website:

People who should NOT get a flu shot

  • People who have a severe allergy to chicken eggs.
  • People who have had a severe reaction to an influenza vaccination.
  • Children younger than 6 months of age (influenza vaccine is not approved for this age group), and
  • People who have a moderate-to-severe illness with a fever (they should wait until they recover to get vaccinated.)
  • People with a history of Guillain–Barré Syndrome (a severe paralytic illness, also called GBS) that occurred after receiving influenza vaccine and who are not at risk for severe illness from influenza should generally not receive vaccine. Tell your doctor if you ever had Guillain-Barré Syndrome. Your doctor will help you decide whether the vaccine is recommended for you.

Since these people can’t be inoculated, their first line of defense is YOU.  They’re relying on herd immunity – the critical moment when so many people are vaccinated that it’s hard for the disease to keep leapfrogging susceptible hosts  until it gets to the truly vulnerable.

So when you skip a vaccination you can afford, you’re putting all those people at risk.  This is also the reason I’m really in favor of innoculating boys against HPV, now that the vaccine’s been approved for them.  Even if most boys won’t be affected by the virus (though more will than you assume; viral-linked anal and oral cancers are on the rise), why would they choose to by carriers for a disease that could sterilize or kill their partners?

So go get your shots, and you can feel a warm glow of happiness (or just the relief of duty fulfilled, if you’re a straw-man Kantian) the next time you see a less than six-month-old baby on the street.  The virus has one fewer avenue of attack thanks to your inoculation.

(poster from the ever-wonderful Vintagraph health and safety section).